Sunvault Energy (SVLT) 10-K 15 Apr 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Apr. 14, 2014	Jun. 28, 2013
Document And Entity Information	'	'	'
Entity Registrant Name	'SunVault Energy, Inc.	'	'
Entity Central Index Key	'0001547716	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Current Fiscal Year End Date	'--12-31	'	'
Is Entity a Well-known Seasoned Issuer?	'No	'	'
Is Entity a Voluntary Filer?	'No	'	'
Is Entity's Reporting Status Current?	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$39,302,250
Entity Common Stock, Shares Outstanding	'	89,211,797	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2013	'	'

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current assets:	'	'
Cash	$11,078	$14,230
Assets held for discontinued operations	'	2,837
Total current assets	11,078	17,067
Assets held for sale (Note 3)	500,000	'
Assets held for discontinued operations	'	4,000
Total assets	511,078	21,067
Current liabilities:	'	'
Accounts payable and accrued liabilities (Note 5)	159,683	'
Liabilities held for discontinued operations	'	60
Convertible debt (Note 4)	50,000	'
Due to related parties (Note 5)	179,391	'
Total liabilities	389,074	60
Nature of operations and continuance of business (Note 1)	'	'
Commitments (Note 8)	'	'
Subsequent events (Note 10)	'	'
Stockholders' equity	'	'
Common stock, 500,000,000 shares authorized, $0.001 par value 65,177,333 and 101,600,000 shares issued and outstanding, respectively	65,177	101,600
Additional paid-in capital	646,922	-15,501
Deficit accumulated during development stage	-590,095	-65,092
Total stockholders' equity	122,004	21,007
Total liabilities and stockholders' equity	$511,078	$21,067

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Stockholders' equity	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	65,177,333	101,600,000
Common stock, shares outstanding	65,177,333	101,600,000

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended		37 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Statements Of Operations	'	'	'
Revenue	'	'	'
Expenses:	'	'	'
General and administrative (Note 5)	517,612	'	517,612
Total expenses	517,612	'	517,612
Net loss from continuing operations	-517,612	'	-517,612
Net loss from discontinued operations	-7,391	-71,957	-72,483
Net loss	($525,003)	($71,957)	($590,095)
Net loss per share, basic and diluted	'	'	'
Continuing operations	($0.01)	'	'
Discontinued operations	'	'	'
Net loss	($0.01)	'	'
Weighted average shares outstanding	86,103,324	95,226,220	'

Statements_of_Stockholders_Equ

Statements of Stockholders' Equity (Deficit) (USD $)	Common Stock	Additional Paid-In Capital	Deficit Accumulated During the Development Stage	Total
Beginning Balance, Amount at Dec. 08, 2010	'	'	'	'
Beginning Balance, Shares at Dec. 08, 2010	'	'	'	'
Shares issued for cash, Shares	80,000,000	'	'	'
Shares issued for cash, Amount	80,000	-76,000	'	4,000
Stockholder capital contribution	'	1,000	'	1,000
Net loss for the year	'	'	-15	-15
Ending Balance, Amount at Dec. 31, 2010	80,000	-75,000	-15	4,985
Ending Balance, Shares at Dec. 31, 2010	80,000,000	'	'	'
Stockholder capital contribution	'	27,099	'	27,099
Net loss for the year	'	'	6,880	6,880
Ending Balance, Amount at Dec. 31, 2011	80,000	-47,901	6,865	38,964
Ending Balance, Shares at Dec. 31, 2011	80,000,000	'	'	'
Shares issued for cash, Shares	21,600,000	'	'	'
Shares issued for cash, Amount	21,600	32,400	'	54,000
Net loss for the year	'	'	-71,957	-71,957
Ending Balance, Amount at Dec. 31, 2012	101,600	-15,501	-65,092	21,007
Ending Balance, Shares at Dec. 31, 2012	101,600,000	'	'	'
Shares issued for cash, Shares	94,000	'	'	'
Shares issued for cash, Amount	94	125,906	'	126,000
Shares returned for cancellation, Shares	-36,850,000	'	'	'
Shares returned for cancellation, Amount	-36,850	36,850	'	'
Shares issued for assets held for sale, Shares	333,333	'	'	'
Shares issued for assets held for sale, Amount	333	499,667	'	500,000
Net loss for the year	'	'	-525,003	-525,003
Ending Balance, Amount at Dec. 31, 2013	$65,177	$646,922	($590,095)	$122,004
Ending Balance, Shares at Dec. 31, 2013	65,177,333	'	'	'

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended		37 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Operating activities	'	'	'
Net loss from continuing operations	($517,612)	'	($517,612)
Changes in operating assets and liabilities:	'	'	'
Accounts payable and accrued liabilities	209,683	'	209,683
Due to related parties	115,281	'	115,281
Net cash flows used in operating activities	-192,648	'	-192,648
Financing activities	'	'	'
Proceeds from related parties	64,110	'	64,110
Proceeds from common stock issued	126,000	'	126,000
Net cash flows provided by financing activities	190,110	'	190,110
Discontinued operations	'	'	'
Operating activities	-614	-43,958	-67,483
Investing activities	'	'	-5,000
Financing activities	'	-37,000	86,099
Net cash used in discontinued operations	-614	-80,958	13,616
Increase (decrease) in cash	-3,152	-80,958	11,078
Cash, beginning of period	14,230	95,188	'
Cash, end of period	11,078	14,230	11,078
Non-cash investing and financing activities:	'	'	'
Common stock issued for the purchase of assets held for sale	500,000	'	500,000
Convertible debt issued for settlement of accounts payable	50,000	'	50,000
Supplemental disclosures:	'	'	'
Interest paid	'	5,046	5,046
Income taxes paid	'	'	$1,212

1_Nature_of_Operations_and_Con

1. Nature of Operations and Continuance of Business	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Nature of Operations and Continuance of Business	'
	Sunvault Energy, Inc. (the “Company) was incorporated in the State of Nevada on December 8, 2010 under the name China Green Clothing Inc. The Company changed its name on April 29, 2011 to My Natural Baby Boutique Inc. then to Organic Treehouse Ltd. on January 5, 2012 then to Sunvault Energy, Inc. on May 24, 2013. The Company’s previous business was in the wholesale and distribution of organic infant and toddler products which was discontinued on May 8, 2013. The Company’s current business is to provide renewables integration into energy production, energy delivery, and energy consumption. The Company is a development stage company as defined by Accounting Standards Codification (“ASC”) 915, “Development Stage Entities”.
	These financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has never generated revenues since inception and is unlikely generate earnings in the immediate or foreseeable future. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to continue operations, and the attainment of profitable operations. As at December 31, 2013, the Company has a working capital deficiency of $377,996 and has accumulated losses of $590,095 since inception. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

2_Significant_Accounting_Polic

2. Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Significant Accounting Policies	'
	(a)	Basis of Presentation
	These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
	(b)	Use of Estimates
	The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to impairment of long-lived assets, fair value of stock-based compensation, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
	(c)	Cash and Cash Equivalents
	The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents.
	(d)	Long-lived Assets
	In accordance with ASC 360, Property, Plant, and Equipment, the Company tests long-lived assets or asset groups for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.
	(e)	Income Taxes
	The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.
	(f)	Foreign Currency Translation
	The Company’s functional and reporting currency is the United States dollar. Transactions may occur in Canadian dollars and management has adopted ASC 830, “Foreign Currency Translation Matters”. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of income.
	(g)	Financial Instruments and Fair Value Measures
	ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1
	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2
	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3
	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, convertible debt, and amounts due to related parties. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
	(h)	Stock-based Compensation
	The Company records stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation” and ASC 505, “Equity Based Payments to Non-Employees”, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.
	(i)	Loss Per Share
	The Company computes earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As at December 31, 2013, the Company has 20,572,333 (2012 – nil) potentially dilutive shares outstanding.
	(j)	Comprehensive Loss
	ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at December 31, 2013 and 2012, the Company has no items that impact comprehensive loss and, therefore, has not included a schedule of comprehensive loss in these financial statements.
	(k)	Reclassifications
	Certain of the prior year figures have been reclassified to conform to the current year’s presentation.
	(l)	Recent Accounting Pronouncements
	The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

3_Assets_Held_For_Sale

3. Assets Held For Sale	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Assets Held For Sale	'
	Assets held for sale consists of solar panels which the Company acquired by issuing 333,333 units with a fair value of $500,000. Refer to Notes 6(a) and 10(h).

4_Convertible_Debt

4. Convertible Debt	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Convertible Debt	'
	(a)	On October 31, 2013, the Company issued a convertible promissory note in exchange for accounts payable of $15,000. The note bears interest at 8% per annum, is unsecured, and due on April 30, 2014. The unpaid amount of principal and accrued interest can be converted at any time at the holder’s option at a price of $0.50 per share of the Company’s common stock. The maturity date will be accelerated to the closing date of any financing transaction in which the Company raises at least $250,000 in gross proceeds. Refer to Note 10(l).
	In accordance with ASC 470-20, “Debt with Conversion and Other Options”, the Company determined that the convertible promissory note contained no embedded beneficial conversion feature as the convertible promissory note was issued with a conversion price higher than the fair market value of the Company’s shares of common stock at the time of issuance.
	(b)	On November 1, 2013, the Company issued a convertible promissory note in exchange for accounts payable of $25,000. The note bears interest at 8% per annum, is unsecured, and due on April 30, 2014. The unpaid amount of principal and accrued interest can be converted at any time at the holder’s option at a price of $0.50 per share of the Company’s common stock. In December 2013, the Company issued additional amount under this convertible promissory note totalling $10,000 under the same terms. The Company is to issue the holder 45,000 shares of common stock upon the initial conversion of this promissory note. The maturity date will be accelerated to the closing date of any financing transaction in which the Company raises at least $250,000 in gross proceeds. Refer to Note 10(c).
	In accordance with ASC 470-20, “Debt with Conversion and Other Options”, the Company determined that the convertible promissory note contained no embedded beneficial conversion feature as the convertible promissory note was issued with a conversion price higher than the fair market value of the Company’s shares of common stock at the time of issuance.

5_Related_Party_Transactions

5. Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Related Party Transactions	'
	(a)	During the year ended December 31, 2013, the Company incurred a salary of $116,250 (2012 – $nil) to the former President of the Company. As at December 31, 2013, $30,000 (2012 - $nil) is owed to the former President of the Company which is included in accounts payable and accrued liabilities.
	(b)	During the year ended December 31, 2013, the Company incurred a salary of $91,144 (2012- $nil) to the former Chief Technology Officer of the Company. As at December 31, 2013, $21,875 (2012 - $nil) is owed to the former Chief Technology Officer of the Company which is included in accounts payable and accrued liabilities.
	(c)	As at December 31, 2013, the amount of $115,281 (2012 - $nil) is owed to a company controlled by a major shareholder for expenses paid on behalf of the Company. The amount due is non-interest bearing, unsecured, and due on demand.
	(d)	As at December 31, 2013, the amount of $30,000 (2012 - $nil) is owed to a significant shareholder which is non-interest bearing, unsecured, and due on demand.
	(e)	As at December 31, 2013, the amount of $34,110 (2012 - $nil) is owed to two directors of the Company which is non-interest bearing, unsecured, and due on demand.
	(f)	On December 1, 2012, the Company repaid the loan of $91,000 plus accrued interest of $5,046 owed to the former President of the Company. During the year ended December 31, 2012, the Company incurred interest expense of $5,046 which has been included in discontinued operations.

6_Common_Stock

6. Common Stock	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Common Stock	'
	(a)	On November 15, 2013, the Company issued 333,333 units with a fair value of $500,000 to a significant shareholder for the purchase solar panels. Each unit consisted of one share common stock and one share purchase warrant exercisable at $2.00 per share expiring two years from the date of issuance. The subscriber is required to exercise the share purchase warrants if the Company’s share price trades at a price of $2.50 or higher for a period of 14 consecutive days. Refer to Note 3.
	(b)	On September 17, 2013, the Company issued 34,000 units at $1.50 per unit for proceeds of $51,000. Each unit consisted of one share of common stock and one share purchase warrant exercisable at $2.00 per share expiring two years from the date of issuance. The subscriber is required to exercise the share purchase warrants if the Company’s share price trades at a price of $2.50 or higher for a period of 14 consecutive days.
	(c)	On September 16, 2013, the Company issued 60,000 units at $1.25 per unit for proceeds of $75,000. Each unit consisted of one share of common stock and one share purchase warrant exercisable at $2.00 per share expiring two years from the date of issuance. The subscriber is required to exercise the share purchase warrants if the Company’s share price trades at a price of $2.50 or higher for a period of 14 consecutive days. Refer to Note 10(m).
	(d)	On August 6, 2013, the Company accepted 36,850,000 shares of common stock for return and cancellation from a significant shareholder in exchange for the issuance of 20,000,000 share purchase warrants and the transfer of intellectual property that it had previously acquired for a nominal amount. The share purchase warrants are exercisable at $2.00 per share expiring ten years from the date of issuance.
	(e)	On June 28, 2013, the Company effected a 20-for-1 forward stock split of its issued shares of common stock. All share amounts have been retroactively restated for all period presented.
	(f)	On May 31, 2013, the Company increased its authorized shares from 75,000,000 to 500,000,000 shares of common stock.
	(g)	On April 18, 2012, the Company issued 1,080,000 shares of common stock at $0.05 per share for proceeds of $54,000.

7_Share_Purchase_Warrants

7. Share Purchase Warrants	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Share Purchase Warrants	'
	The following table summarizes the continuity of share purchase warrants:
			Number of				Weighted average exercise price
			warrants				$
			(a)				(b)
	Balance, December 31, 2011 and 2012			–				–
	Issued			20,427,333				2
	Balance, December 31, 2013			20,427,333				2
	As at December 31, 2013, the following share purchase warrants were outstanding:
	Number of warrants				Exercise				Expiry date
					price
					$
		60,000				2			16-Sep-15
		34,000				2			17-Sep-15
		333,333				2			15-Nov-15
		20,000,000				2			6-Aug-23
		20,427,333

8_Commitment

8. Commitment	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Commitment	'
	On December 9, 2013, the Company entered into a licensing agreement pursuant to which the Company has been granted a royalty-bearing, exclusive license to certain patented inventions. The Company has agreed to pay the licensor $3,000 and issue shares of common stock equal to a fair value of $30,000 on or before January 8, 2014. Refer to Note 10(e). The Company will pay royalties to the licensor calculated based on 4% of net sales for licensed products and processes. The minimum royalty payments are to be paid in advance on a quarterly basis as follows: December 3, 2018 - $500; year 2019 - $2,000; year 2020 - $4,000; year 2021 - $6,000; year 2022 - $8,000; and $10,000 for 2023 and every year thereafter for the life of the agreement. If the first sale of a licensed product occurs before 2019, the first minimum royalty payment will be due on December 31 of the year in which the first sale occurred and the due dates for the subsequent minimum royalty payments will be adjusted accordingly. The Company must provide funding of at least $50,000 by January 6, 2014 for research by the licensor in the area of electrochemical based solar cells with energy storage capacity. In addition, the Company must pay the licensor milestone payments as follows: $5,000 upon completion of a working prototype due on March 31, 2018 and $10,000 upon its first commercial sale due on March 31, 2019. The Company must execute the first commercial sales of products to a retail customer on or before March 31, 2019 or the licensor has the right to terminate the agreement. The term of this license will continue until the latter of the date that no licensed patent remains a pending application or an unforceable patent, or the date on which the licensee’s obligation to pay royalties expires.

9_Income_Taxes

9. Income Taxes	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Income Taxes	'
	The Company has net operating losses carried forward of $596,960 available to offset taxable income in future years which expires beginning in fiscal 2022.
	The Company is subject to United States federal and state income taxes at an approximate rate of 34%. The reconciliation of the provision for income taxes at the United States federal statutory rate compared to the Company’s income tax expense as reported is as follows:
		2013			2012
		$			$
	Income tax recovery at statutory rate		(178,501	)		(24,465	)
	Valuation allowance change		178,501			24,465
	Provision for income taxes		–			–
	The significant components of deferred income tax assets and liabilities as at December 31, 2013 and 2012 are as follows:
		2013			2012
		$			$
	Net operating losses carried forward		202,966			24,465
	Valuation allowance		(202,966	)		(24,465	)
	Net deferred income tax asset		–			–

10_Subsequent_Events

10. Subsequent Events	12 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
Subsequent Events	'
	(a)	On January 16, 2014, the Company entered into an agreement with a company controlled by the new President of the Company whereby the Company is to pay $10,000 per month which is to be paid with shares of common stock of the Company until the Company has adequate funding. If the agreement is terminated by the Company without cause or as a result of a change in control, this company will be entitled to termination pay of $240,000.
	(b)	On February 6, 2014, the Company adopted the 2014 Stock Option Plan which permits the Company to grant stock options for to 12,968,800 shares of common stock to officers, directors, employees, and consultants. The Board of Directors will determine the exercise price and vesting schedule for stock options granted. The maximum term of stock options granted is five years.
	(c)	On February 14, 2014, the Company issued 350,000 shares of common stock to settle the convertible debt of $35,000. Refer to Note 4(b).
	(d)	On February 17, 2014, the Company granted 3,100,000 stock options to officer, directors, and consultants of the Company at an exercise price of $0.10 per share expiring on February 17, 2019.
	(e)	On February 18, 2014, the Company issued 300,000 shares of common stock pursuant to a licensing agreement. Refer to Note 8.
	(f)	On February 19, 2014, the Company entered into a share purchase agreement to acquire 100% of the shares of 1454004 Alberta Ltd., which holds 100% of the issued and outstanding shares of CleanGen Power Corp. and 50% of the issued and outstanding shares of CleanGen Inc., in exchange for 19,500,000 shares of common stock of the Company. CleanGen Inc. is a company based in Alberta, Canada that operates Cutting Edge Tire Recycling LP, CleanGen Aboriginal HR Services Ltd., and Coole Immersive Inc.
	(g)	On March 1, 2014, the Company entered into an agreement whereby it has agreed to sponsor a research program of mutual interest and benefit for the Company and the researcher. The Company has agreed to reimburse the researcher for all direct and indirect costs incurred in the performance of the research not to exceed $85,000 unless agreed upon by the Company. Payments are to be made in advance as follow: $42,500 due upon signing of this agreement and invoicing by the researcher and $42,500 due on May 1, 2014. The agreement may be terminated by either party upon 60 days written notice to the other party. Upon termination by either party, the researcher will be reimbursed for all costs and non-cancellable commitments incurred up to and including the effective date of termination.
	(h)	On March 5, 2014, the Company sold the solar panels that were held for sale as at December 31, 2013 to 50% owned CleanGen Inc., which was acquired by the Company as disclosed in Note 10(f), in exchange for $525,000 worth of preferred stock of CleanGen Inc. and a $375,000 promissory note. Upon the Company receiving the preferred stock, it controls 56% of the voting shares of CleanGen Inc.
	(i)	On April 1, 2014, the Company issued 3,333,334 shares of common stock to acquire 100% of the shares of Eco-West Transport Inc., a company based in Alberta, Canada, which is in the business of providing trucking transportation services.
	(j)	On April 4, 2014, the Company issued 120,000 shares of common stock to a company controlled by the President of the Company to settle management services of $30,000 provided subsequent to December 31, 2013.
	(k)	On April 4, 2014, the Company issued 50,000 shares of common stock to the Chief Technology Officer of the Company to settle management services of $6,000 provided subsequent to December 31, 2013.
	(l)	On April 7, 2014, the Company issued 191,130 shares of common stock to settle the convertible debt of $15,000. Refer to Note 4(a).
	(m)	On April 7, 2014, the Company issued 190,000 shares of common stock to re-price the subscription price for the private placement shares issued on September 16, 2013. Refer to Note 6(c).

2_Significant_Accounting_Polic1

2. Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Significant Accounting Policies Policies	'
Basis of Presentation	'
	These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
Use of Estimates	'
	The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to impairment of long-lived assets, fair value of stock-based compensation, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Cash and Cash Equivalents	'
	The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents.
Long-lived Assets	'
	In accordance with ASC 360, Property, Plant, and Equipment, the Company tests long-lived assets or asset groups for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.
Income Taxes	'
	The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.
Foreign Currency Transactions	'
	The Company’s functional and reporting currency is the United States dollar. Transactions may occur in Canadian dollars and management has adopted ASC 830, “Foreign Currency Translation Matters”. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of income.
Financial Instruments and Fair Value Measures	'
	ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1
	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2
	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3
	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, convertible debt, and amounts due to related parties. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
Stock-based Compensation	'
	The Company records stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation” and ASC 505, “Equity Based Payments to Non-Employees”, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.
Loss Per Share	'
	The Company computes earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As at December 31, 2013, the Company has 20,572,333 (2012 – nil) potentially dilutive shares outstanding.
Comprehensive Loss	'
	ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at December 31, 2013 and 2012, the Company has no items that impact comprehensive loss and, therefore, has not included a schedule of comprehensive loss in these financial statements.
Reclassifications	'
	Certain of the prior year figures have been reclassified to conform to the current year’s presentation.
Recent Accounting Pronouncements	'
	The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

7_Share_Purchase_Warrants_Tabl

7. Share Purchase Warrants (Tables)	12 Months Ended
	Dec. 31, 2013
Share Purchase Warrants Tables	'
Share purchase warrants	'
	The following table summarizes the continuity of share purchase warrants:
			Number of				Weighted average exercise price
			warrants				$
			(a)				(b)
	Balance, December 31, 2011 and 2012			–				–
	Issued			20,427,333				2
	Balance, December 31, 2013			20,427,333				2
Share purchase warrants exercise price	'
	As at December 31, 2013, the following share purchase warrants were outstanding:
	Number of warrants				Exercise				Expiry date
					price
					$
		60,000				2			16-Sep-15
		34,000				2			17-Sep-15
		333,333				2			15-Nov-15
		20,000,000				2			6-Aug-23
		20,427,333

9_Income_Taxes_Tables

9. Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Taxes Tables	'
Provision for income taxes	'
	The reconciliation of the provision for income taxes at the United States federal statutory rate compared to the Company’s income tax expense as reported is as follows:
		2013			2012
		$			$
	Income tax recovery at statutory rate		(178,501	)		(24,465	)
	Valuation allowance change		178,501			24,465
	Provision for income taxes		–			–
Deferred income tax assets and liabilities	'
	The significant components of deferred income tax assets and liabilities as at December 31, 2013 and 2012 are as follows:
		2013			2012
		$			$
	Net operating losses carried forward		202,966			24,465
	Valuation allowance		(202,966	)		(24,465	)
	Net deferred income tax asset		–			–

2_Significant_Accounting_Polic2

2. Significant Accounting Policies (Details Narrative)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Significant Accounting Policies Details Narrative	'	'
Potentially dilutive shares outstanding	20,572,333	'

5_Related_Party_Transactions_D

5. Related Party Transactions (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Former President	'	'
Salary	$116,250	$0
Amount owed to related party	30,000	0
Repayment of loan	91,000	'
Accrued interest	5,046	'
Interest expense	5,046	'
Former Chief Technology Officer	'	'
Salary	91,144	0
Amount owed to related party	21,875	0
Major Shareholder	'	'
Amount owed to related party	115,281	0
Significant Shareholder	'	'
Amount owed to related party	30,000	0
Two Directors	'	'
Amount owed to related party	$34,110	$0

7_Share_Purchase_Warrants_Deta

7. Share Purchase Warrants (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Share Purchase Warrants Details	'
Number of Options Outstanding, Beginning	'
Number of Warrants Issued	20,427,333
Number of Warrants Outstanding, Ending	20,427,333
Weighted Average Exercise Price Outstanding, Beginning	'
Weighted Average Exercise Price Issued	$2
Weighted Average Exercise Price Outstanding, Ending	$2

7_Share_Purchase_Warrants_Deta1

7. Share Purchase Warrants (Details 1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Number of Warrants	20,427,333	'
Weighted Average Exercise Price	$2	'
Warrant One [Member]	'	'
Number of Warrants	60,000	'
Weighted Average Exercise Price	$2	'
Expiry date	16-Sep-15	'
Warrant Two [Member]	'	'
Number of Warrants	34,000	'
Weighted Average Exercise Price	$2	'
Expiry date	17-Sep-15	'
Warrant Three [Member]	'	'
Number of Warrants	333,333	'
Weighted Average Exercise Price	$2	'
Expiry date	15-Nov-15	'
Warrant Four [Member]	'	'
Number of Warrants	20,000,000	'
Weighted Average Exercise Price	$2	'
Expiry date	6-Aug-23	'

9_Income_Taxes_Details

9. Income Taxes (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Income Taxes Details	'	'
Income tax recovery at statutory rate	($178,501)	($24,465)
Less valuation allowance	178,501	24,465
Provision for income taxes	'	'

9_Income_Taxes_Details_1

9. Income Taxes (Details 1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Income Taxes Details 1	'	'
Net operating losses carried forward	$202,966	$24,465
Valuation allowance	-202,966	-24,465
Net deferred income tax asset	'	'